PAPER Hedera P, Friedman JH
SEARCH RESULTS
331159 RESULTS
PAPER Turturro S, Shen X, Shyam R, Yue BY, Ying H
Effects of mutations and deletions in the human optineurin gene.
Springerplus. 2014;3:99. Epub 2014 Feb 19 PubMed: 24683533PAPER Wang F, Lu Y, Qi F, Su Q, Wang L, You C, Che F, Yu J
Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells.
Mol Med Rep. 2014 Jun;9(6):2453-8. Epub 2014 Mar 28 PubMed: 24682253PAPER Vinay Kumar C, Kumar KM, Swetha R, Ramaiah S, Anbarasu A
Protein aggregation due to nsSNP resulting in P56S VABP protein is associated with amyotrophic lateral sclerosis.
J Theor Biol. 2014 Aug 7;354:72-80. Epub 2014 Mar 27 PubMed: 24681403PAPER Nichols NL, Johnson RA, Satriotomo I, Mitchell GS
Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.
Respir Physiol Neurobiol. 2014 Jun 15;197:19-28. Epub 2014 Mar 28 PubMed: 24681328PAPER Ahn SW, Jeon GS, Kim MJ, Shon JH, Kim JE, Shin JY, Kim SM, Kim SH, Ye IH, Lee KW, Hong YH, Sung JJ
Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
J Neurol Sci. 2014 May 15;340(1-2):112-6. Epub 2014 Mar 12 PubMed: 24680562PAPER Grassinger J, Khomenko A, Hart C, Baldaranov D, Johannesen SW, Mueller G, Schelker R, Schulte-Mattler W, Andreesen R, Bogdahn U
Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis.
Cytokine. 2014 May;67(1):21-8. Epub 2014 Feb 26 PubMed: 24680478PAPER Carrillo-Mora P, Luna R, Colín-Barenque L
Amyloid beta: multiple mechanisms of toxicity and only some protective effects?
Oxid Med Cell Longev. 2014;2014:795375. Epub 2014 Feb 5 PubMed: 24683437PAPER Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Peña V
Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?
Oxid Med Cell Longev. 2014;2014:497802. Epub 2014 Jan 20 PubMed: 24683436PAPER Beauchet O, Launay CP, Allali G, Herrmann FR, Annweiler C
Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.
Drugs Aging. 2014 May;31(5):363-72. PubMed: 24683126PAPER Kim GH, Lee JH, Seo SW, Ye BS, Cho H, Kim HJ, Noh Y, Yoon CW, Chin JH, Oh SJ, Kim JS, Choe YS, Lee KH, Kim ST, Jeong JH, Na DL
Seoul criteria for PiB(-) subcortical vascular dementia based on clinical and MRI variables.
Neurology. 2014 Apr 29;82(17):1529-35. Epub 2014 Mar 28 PubMed: 24682969PAPER Krishnan S, Rani P
Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
Biol Trace Elem Res. 2014 May;158(2):158-65. Epub 2014 Mar 30 PubMed: 24682919PAPER Hermansson E, Schultz S, Crowther D, Linse S, Winblad B, Westermark G, Johansson J, Presto J
The chaperone domain BRICHOS prevents CNS toxicity of amyloid-β peptide in Drosophila melanogaster.
Dis Model Mech. 2014 Jun;7(6):659-65. Epub 2014 Mar 28 PubMed: 24682783PAPER Wang S, Zhou SL, Min FY, Ma JJ, Shi XJ, Bereczki E, Wu J
mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice.
Metab Brain Dis. 2014 Sep;29(3):729-36. Epub 2014 Mar 30 PubMed: 24682776PAPER Yang Y, Wang M, Lv B, Ma R, Hu J, Dun Y, Sun S, Li G
Sphingosine kinase-1 protects differentiated N2a cells against beta-amyloid25-35-induced neurotoxicity via the mitochondrial pathway.
Neurochem Res. 2014 May;39(5):932-40. Epub 2014 Mar 30 PubMed: 24682752Current Filters
No filters selected